Bella One PAP
The Bella One PAP is a FDA-approved test to screen for presence of human papillomavirus (HPV) DNA along with genotyping for high risk strains of HPV.
The molecular panel also screens for presence of sexually transmitted infections and bacterial vaginosis pathogens that pose a threat to women's health. Often symptom-less, these gynecological conditions can cause irreversible damage to women’s reproductive system and overall health making it all the more important for sexually active women to be tested regularly.
Boost Effectiveness of Patient Testing
Awareness about the link between HPV and cervical cancer has grown exponentially – leading to earlier detection and prevention. The CDC estimates that up to 93 percent of cervical cancers can be prevented. And yet, 33 percent of the 14,000 women who are diagnosed annually will die.
Why Bella One PAP?
The Bella One PAP screens for presence of Human Papilloma Virus (HPV) DNA as well as precancerous cells to determine whether a woman is at high-risk for developing cervical precancerous or cancerous conditions. – in addition Bella One Pap is design to test for a host of other infectious gynecological conditions.
The Bella One PAP® Panel Menu
Overall 100% sensitivity and 99.8% specificity
Sample Type: Cervical Vaginal
STI Molecular Panel
BV Molecular Panel
Herpes simplex virus
type 1 & 2 (HSV1 + HSV2)
Megasphaera Type 1
associated bacteria 2